ACRGF - What Does the FDA's CBD Public Hearing Mean for Hemp Stocks?

The US Food and Drug Administration (FDA) held a public hearing last week to obtain scientific data about the safety, manufacturing, product quality, labeling, marketing, and sale of products containing cannabis or cannabis-derived compounds. However, despite lasting 10 hours and featuring over 100 speakers, the FDA public hearing left a number of questions unanswered.

Unsurprisingly, the lack of clarity caused hemp stocks to tumble Monday morning as investors digested early news from the event. It also left market watchers wondering what will happen next.

Let’s take a look at what went on during the ...